Hepatitis B vaccination in diabetic patients: Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen

Diabetes Care

Volumn 20, Issue 2, 1997, Pages 148-151

  Douvin, Catherine ^a   Simon, Dominique ^a,b   Charles, Marie Aline ^a,b   Deforges, Lionel ^a   Bierling, Philippe ^a   Lehner, Valérie ^c   Budkowska, Agata ^d   Dhumeaux, Daniel ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM   (France)

^c SmithKline Beecham   (France)

^d INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ANTIBODY PRODUCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HEPATITIS B; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; SINGLE BLIND PROCEDURE; VACCINATION;

EID: 0031016571     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.2.148     Document Type: Article

References (16)

1. Casey JJ: Host defense abnormalities in diabetic patients. Diabetes Mellitus 5:219-222, 1981
2. Madalinski K, Brzosko WJ, Malczewski B, Czyzyk A: Au/HAA in sera of diabetic patients. Lancet i:701-702, 1971
3. Savagnone E, Caruso V, Mondello P, Patti S, Spicola L, Spano C: Hepatitis B virus in diabetic patients. Acta Diabetol Lat 17:207-211, 1980
4. Douvin C, Simon D, Zinelabidine H, Wirquin v, Perlemuter L, Dhumeaux D: An outbreak of hepatitis B in an endocrinology unit traced to a capillary-blood sampling device. N Engl J Med 322:57, 1990
5. Polish LB, Shapiro CN, Bauer F, Klotz P, Ginier P, Roberto RR, Margolis HS, Alter MJ: Nosocomial transmission of hepatitis B virus associated with the use of a spring-loaded finger-stick device. N Engl J Med 326:721-725, 1992
6. Pozzilli P, Arduini P, Visalli N, Sutherland J, Pezzella M, Galli C, Corradini SG, Biasio L, Gale EAM, Andreani D: Reduced protection against hepatitis B virus following vaccination in patients with type I (insulin-dependent) diabetes. Diabetologia 30:817-819, 1987
7. Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz AJ, Brink SJ, Dienstag JL, Awdeh Z, Yunis EJ: Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 321:708-712, 1989
8. Milich DR, Thornton GB, Neurath AR, Kent SB, Michel ML, Tiollais P: Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science 228:1195-1199, 1985
9. Yap I, Guan R, Chan SH: Study on the comparative immunogenicity of a recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein with non pre-S containing vaccines. J Gastroenterol Hepatol 10:51-55, 1995
10. Tron F, Degos F, Bréchot C, Courouce AM, Goudeau A, Marie FN, Saliou P, Laplanche A, Benhamou JP, Girard M: Immunological properties of a recombinant hepatitis B vaccine produced in mammalian cells and containing the S and pre-S2 sequences. In Progress in Hepatitis B Immunization. P Coursaget, MJ long, Eds. Paris, John Libbey Eurotext, 1990, p. 227-237
11. Harris MI, Cowie CC, Howie LJ: Self-monitoring of blood glucose by adults with diabetes in the United States population. Diabetes Care 16:1116-1123, 1993
12. Pillot J, Poynard T, Elias A, Maillard J, Lazizi Y, Brancer M, Dubreuil P, Budkowska A, Chaput JC: Weak immunogenicity of the pre S2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccine. Vaccine 13:289-294, 1995
13. Mittel KK, Mickey MR, Singal DP, Terasaki PI: Serotyping for hemotransplantation. XVIII. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation 6:913-927, 1986
14. Bidwell JL, Bignon JD: DNA-RFLP methods and interpretation scheme for HLA DR and DQ typing. Eur J Immunogenet 18:5-22, 1991
15. Shaw FE, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ, Roehm RR, Talley WS, Hadder S: Effect of anatomic injection site, age, and smoking on the immune response to hepatitis B vaccination. Vaccine 7:425-430, 1989
16. Itoh Y, Takai E, Ohnuma H, Kitajima K, Tsuda F, Machid A, Mishiro S, Nakamura T, Miyakawa Y, Mayumi M: A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci USA 83:9174-9178, 1986